Association of miR-34a, miR-130a, miR-150 and miR-155 polymorphisms with the risk of ischemic stroke

Choi,Gun  Ho; Ko,Ki  Han; Kim,Jung  Oh; Kim,Jinkwon; Oh,Seung  Hun; Han,In  Bo; Cho,Kyung  Gi; Kim,Ok  Joon; Bae,Jinkun; Kim,Nam  Keun

doi:10.3892/ijmm.2016.2609

Association of miR-34a, miR-130a, miR-150 and miR-155 polymorphisms with the risk of ischemic stroke

Authors:
- Gun Ho Choi
- Ki Han Ko
- Jung Oh Kim
- Jinkwon Kim
- Seung Hun Oh
- In Bo Han
- Kyung Gi Cho
- Ok Joon Kim
- Jinkun Bae
- Nam Keun Kim
View Affiliations

Affiliations: Department of Biomedical Science, College of Life Science, CHA University, Seongnam 463‑400, Republic of Korea, Department of Neurology, CHA Bundang Medical Center, School of Medicine, CHA University, Seongnam 463-712, Republic of Korea, Department of Neurosurgery, CHA Bundang Medical Center, School of Medicine, CHA University, Seongnam 463-712, Republic of Korea, Department of Emergency Medicine, CHA Bundang Medical Center, School of Medicine, CHA University, Seongnam 463-712, Republic of Korea
Published online on: May 25, 2016 https://doi.org/10.3892/ijmm.2016.2609
Pages: 345-356

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

MicroRNAs (miRNAs or miRs) are small (19-23 nt) non-coding RNA molecules that are endogenous regulators of gene expression. Previous studies have found that some miRNAs are related to the progression of ischemia in the cerebral artery. Furthermore, a recent study found a significant association between miRNA single nucleotide polymorphisms (SNPs) and the risk of ischemic stroke. Therefore, it may be valuable to investigate associations between megakaryocyte formation-related miRNA polymorphisms and the prevalence of ischemic stroke. We thus conducted a case-control study of 1,000 individuals who were screened for 4 miRNA polymorphisms (miR‑34a rs6577555C>A, miR-130a rs731384C>T, miR-150 rs73056059G>A and miR‑155 rs767649T>A) by PCR-RFLP analysis. The study population comprised 596 patients with ischemic stroke and 404 control subjects without any history of neurological disorders. We observed associations between miRNA polymorphisms and individual stroke subtypes. The miR‑150 polymorphisms were significantly associated with ischemic stroke subgroups, such as left anterior descending artery (LAD) disease [GG vs. AA: adjusted odds ratio (AOR), 1.922; 95% confidence interval (CI), 1.003-3.681] and cardioembolism (GG vs. AA: AOR, 2.996; 95% CI, 1.293-6.939). Additionally, Cox proportional analysis indicated that the miR‑150GA genotype was associated with survival in patients with ischemic stroke [adjusted hazard ratio (HR), 2.063; 95% CI, 1.142-3.727; P=0.017] and with the LAD subgroup [adjusted HR, 3.021; 95% CI, 1.345-6.785; P=0.008]. Our findings suggest that miR‑150 polymorphisms may contribute to the development of ischemic stroke and may potentially act as biomarkers to predict the risk of ischemic stroke. To the best of our knowledge, this is the first study to evaluate the association between miRNA polymorphisms (miR-34aC>A, miR-130aC>T, miR-150G>A and miR-155T>A) and ischemic stroke.

View Figures

View References

1	Donnan GA, Fisher M, Macleod M and Davis SM: Stroke. Lancet. 371:1612–1623. 2008. View Article : Google Scholar : PubMed/NCBI
2	Goldstein LB, Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G, Hill M, Howard G, Howard VJ, Jacobs B, et al: Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation. 103:163–182. 2001. View Article : Google Scholar : PubMed/NCBI
3	Mustacchi P: Risk factors in stroke. West J Med. 143:186–192. 1985.PubMed/NCBI
4	Arboix A: Cardiovascular risk factors for acute stroke: Risk profiles in the different subtypes of ischemic stroke. World J Clin Cases. 3:418–429. 2015. View Article : Google Scholar : PubMed/NCBI
5	Mohr JP, Caplan LR, Melski JW, Goldstein RJ, Duncan GW, Kistler JP, Pessin MS and Bleich HL: The Harvard Cooperative Stroke Registry: A prospective registry. Neurology. 28:754–762. 1978. View Article : Google Scholar : PubMed/NCBI
6	Cosemans JM, Angelillo-Scherrer A, Mattheij NJ and Heemskerk JW: The effects of arterial flow on platelet activation, thrombus growth, and stabilization. Cardiovasc Res. 99:342–352. 2013. View Article : Google Scholar : PubMed/NCBI
7	Shah AB, Beamer N and Coull BM: Enhanced in vivo platelet activation in subtypes of ischemic stroke. Stroke. 16:643–647. 1985. View Article : Google Scholar : PubMed/NCBI
8	Sharma SC, Vijayan GP, Suri ML and Seth HN: Platelet adhesiveness in young patients with ischaemic stroke. J Clin Pathol. 30:649–652. 1977. View Article : Google Scholar : PubMed/NCBI
9	O'Malley T, Langhorne P, Elton RA and Stewart C: Platelet size in stroke patients. Stroke. 26:995–999. 1995. View Article : Google Scholar : PubMed/NCBI
10	George JN: Platelets. Lancet. 355:1531–1539. 2000. View Article : Google Scholar : PubMed/NCBI
11	Pease DC: An electron microscopic study of red bone marrow. Blood. 11:501–526. 1956.PubMed/NCBI
12	Ambros V: The functions of animal microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
13	Bartel DP: MicroRNAs: Target recognition and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
14	Aumiller V and Forstemann K: Roles of microRNAs beyond development - metabolism and neural plasticity. Biochim Biophys Acta. 692–696:2008.1779
15	Merkerova M, Belickova M and Bruchova H: Differential expression of microRNAs in hematopoietic cell lineages. Eur J Haematol. 81:304–310. 2008. View Article : Google Scholar : PubMed/NCBI
16	Carissimi C, Fulci V and Macino G: MicroRNAs: Novel regulators of immunity. Autoimmun Rev. 8:520–524. 2009. View Article : Google Scholar : PubMed/NCBI
17	Tan KS, Armugam A, Sepramaniam S, Lim KY, Setyowati KD, Wang CW and Jeyaseelan K: Expression profile of MicroRNAs in young stroke patients. PLoS One. 4:e76892009. View Article : Google Scholar : PubMed/NCBI
18	Liu DZ, Tian Y, Ander BP, Xu H, Stamova BS, Zhan X, Turner RJ, Jickling G and Sharp FR: Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J Cereb Blood Flow Metab. 30:92–101. 2010. View Article : Google Scholar
19	Jeon YJ, Kim OJ, Kim SY, Oh SH, Oh D, Kim OJ, Shin BS and Kim NK: Association of the miR-146a, miR-149, miR-196a2, and miR-499 polymorphisms with ischemic stroke and silent brain infarction risk. Arterioscler Thromb Vasc Biol. 33:420–430. 2013. View Article : Google Scholar
20	Edelstein LC and Bray PF: MicroRNAs in platelet production and activation. Blood. 117:5289–5296. 2011. View Article : Google Scholar : PubMed/NCBI
21	Dangwal S and Thum T: MicroRNAs in platelet biogenesis and function. Thromb Haemost. 108:599–604. 2012. View Article : Google Scholar : PubMed/NCBI
22	Goldstein LB, Jones MR, Matchar DB, Edwards LJ, Hoff J, Chilukuri V, Armstrong SB and Horner RD: Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria. Stroke. 32:1091–1098. 2001. View Article : Google Scholar : PubMed/NCBI
23	Kim OJ, Hong SH, Oh SH, Kim TG, Min KT, Oh D and Kim NK: Association between VEGF polymorphisms and homocysteine levels in patients with ischemic stroke and silent brain infarction. Stroke. 42:2393–2402. 2011. View Article : Google Scholar : PubMed/NCBI
24	Jeon YJ, Kim YR, Lee BE, Choi YS, Kim JH, Shin JE, Rah H, Cha SH, Lee WS and Kim NK: Genetic association of five plasminogen activator inhibitor-1 (PAI-1) polymorphisms and idiopathic recurrent pregnancy loss in Korean women. Thromb Haemost. 110:742–750. 2013. View Article : Google Scholar : PubMed/NCBI
25	Bushati N and Cohen SM: MicroRNAs in neurodegeneration. Curr Opin Neurobiol. 18:292–296. 2008. View Article : Google Scholar : PubMed/NCBI
26	Chuang JC and Jones PA: Epigenetics and microRNAs. Pediatr Res. 61:24R–29R. 2007. View Article : Google Scholar : PubMed/NCBI
27	Saetrom P, Snøve O Jr and Rossi JJ: Epigenetics and microRNAs. Pediatr Res. 61:17R–23R. 2007. View Article : Google Scholar : PubMed/NCBI
28	Gao H, Guddeti RR, Matsuzawa Y, Liu LP, Su LX, Guo D, Nie SP, Du J and Zhang M: Plasma levels of microRNA-145 are associated with severity of coronary artery disease. PLoS One. 10:e01234772015. View Article : Google Scholar : PubMed/NCBI
29	Lujambio A and Esteller M: CpG island hypermethylation of tumor suppressor microRNAs in human cancer. Cell Cycle. 6:1455–1459. 2007. View Article : Google Scholar : PubMed/NCBI
30	Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, et al: MicroRNA expression profiles classify human cancers. Nature. 435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
31	Zhang H, Li Y and Lai M: The microRNA network and tumor metastasis. Oncogene. 29:937–948. 2010. View Article : Google Scholar
32	Jeyaseelan K, Lim KY and Armugam A: MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke. 39:959–966. 2008. View Article : Google Scholar : PubMed/NCBI
33	Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Röxe T, Müller-Ardogan M, et al: Circulating microRNAs in patients with coronary artery disease. Circ Res. 107:677–684. 2010. View Article : Google Scholar : PubMed/NCBI
34	Laterza OF, Lim L, Garrett-Engele PW, Vlasakova K, Muniappa N, Tanaka WK, Johnson JM, Sina JF, Fare TL, Sistare FD and Glaab WE: Plasma microRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem. 55:1977–1983. 2009. View Article : Google Scholar : PubMed/NCBI
35	Navarro F, Gutman D, Meire E, Cáceres M, Rigoutsos I, Bentwich Z and Lieberman J: miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53. Blood. 114:2181–2192. 2009. View Article : Google Scholar : PubMed/NCBI
36	Garzon R, Pichiorri F, Palumbo T, Iuliano R, Cimmino A, Aqeilan R, Volinia S, Bhatt D, Alder H, Marcucci G, et al: MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci USA. 103:5078–5083. 2006. View Article : Google Scholar : PubMed/NCBI
37	Barroga CF, Pham H and Kaushansky K: Thrombopoietin regulates c-Myb expression by modulating micro RNA 150 expression. Exp Hematol. 36:1585–1592. 2008. View Article : Google Scholar : PubMed/NCBI
38	Georgantas RW III, Hildreth R, Morisot S, Alder J, Liu CG, Heimfeld S, Calin GA, Croce CM and Civin CI: CD34⁺ hematopoietic stem-progenitor cell microRNA expression and function: A circuit diagram of differentiation control. Proc Natl Acad Sci USA. 104:2750–2755. 2007. View Article : Google Scholar
39	Ramsay RG: c-Myb a stem-progenitor cell regulator in multiple tissue compartments. Growth Factors. 23:253–261. 2005. View Article : Google Scholar : PubMed/NCBI
40	Lu J, Guo S, Ebert BL, Zhang H, Peng X, Bosco J, Pretz J, Schlanger R, Wang JY, Mak RH, et al: MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev Cell. 14:843–853. 2008. View Article : Google Scholar : PubMed/NCBI
41	Barnett HJ: Platelet and coagulation function in relation to thromboembolic stroke. Adv Neurol. 16:45–70. 1977.PubMed/NCBI
42	Kalendovsky Z, Austin J and Steele P: Increased platelet aggregability in young patients with stroke. Diagnosis and therapy. Arch Neurol. 32:13–20. 1975. View Article : Google Scholar : PubMed/NCBI
43	van Rooy MJ and Pretorius E: Metabolic syndrome, platelet activation and the development of transient ischemic attack or thromboembolic stroke. Thromb Res. 135:434–442. 2015. View Article : Google Scholar : PubMed/NCBI
44	Grabe N: AliBaba2: Context specific identification of transcription factor binding sites. In Silico Biol. 2:S1–S15. 2002.PubMed/NCBI
45	Momoeda M, Kawase M, Jane SM, Miyamura K, Young NS and Kajigaya S: The transcriptional regulator YY1 binds to the 5′-terminal region of B19 parvovirus and regulates P6 promoter activity. J Virol. 68:7159–7168. 1994.
46	Lee GR: Role of YY1 in long-range chromosomal interactions regulating Th2 cytokine expression. Transcription. 5:e279762014. View Article : Google Scholar
47	Funahashi N, Hirota Y, Nakagawa K, Sawada N, Watanabe M, Suhara Y and Okano T: YY1 positively regulates human UBIAD1 expression. Biochem Biophys Res Commun. 460:238–244. 2015. View Article : Google Scholar : PubMed/NCBI